-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

631. Myeloproliferative Syndromes and Chronic Myeloid Leukemia: Basic and Translational: Poster II

Symposia: Chronic Myeloid Leukemia: Biology and Pathophysiology, excluding Therapy Program: Oral and Poster Abstracts
Type: Poster
Sunday, December 10, 2023: 6:00 PM-8:00 PM
Halls G-H (San Diego Convention Center)

Zanshe Thompson, PhD, MS1, Li Z Luo, PhD2*, Liping Li, MD, PhD3*, Bowen Wang, MS3*, Jung-Hyun Kim, PhD3*, Hyunsung Woo, BS4*, Bailey West, BS5*, Anandi Krishnan, PhD6*, Leslie Cope, PhD7*, Alison R. Moliterno, MD8, Jerry L. Spivak, MD9 and Linda Resar, MD10

1Division of Hematology, The Johns Hopkins University School of Medicine, Baltimore, MD
2Department of Medicine, Division of Hematology, The Johns Hopkins University School of Medicine, Baltimore, MD
3The Johns Hopkins University School of Medicine, Baltimore, MD
4Whiting School of Engineering, The Johns Hopkins University, Baltimore, MD
5Pathobiology Graduate Program, Johns Hopkins University School of Medicine, Baltimore, MD
6Stanford University, Palo Alto, CA
7Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD
8Division of Hematology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD
9Department of Medicine, Division of Hematology, Johns Hopkins University School of Medicine, Baltimore, MD
10Division of Hematology, Departments of Medicine, Oncology & Pathology, The Johns Hopkins University School of Medicine, Baltimore, MD

Jani Huuhtanen, M.D.1,2,3*, Shady Adnan-Awad, M.D., Ph.D4*, Jason Theodoropoulos, M.Sc.5*, Sofia Forstén, M.Sc.4*, Rebecca Warfvinge, M.Sc.6*, Olli Dufva, M.D., Ph.D.7*, Jonas Bouhlal7*, Parashar Dhapola, M.Sc.8*, Hanna Duàn, M.Sc.9*, Essi Laajala, Ph.D.7*, Tiina Kasanen4*, Jay Klievink, M.Sc.10*, Mette Ilander, Ph.D.4*, Taina Jaatinen, Ph.D.11*, Ulla Olsson-Strömberg, M.D., Ph.D.12*, Henrik Hjorth-Hansen, M.D., Ph.D.13, Andreas Burchert, MD14, Göran Karlsson, Ph.D.15*, Anna Kreutzman, Ph.D.4*, Harri Lähdesmäki, Ph.D.16* and Satu Mustjoki, MD, PhD4

1Translational Immunology Research Program and Department of Clinical Chemistry and Hematology, University of Helsinki, Helsinki, Finland
2iCAN Digital Precision Cancer Medicine Flagship, Helsinki, Finland
3Hematology Research Unit Helsinki, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland
4University of Helsinki, Helsinki, Finland
5Hematology Research Unit Helsinki, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland
6Labratory Medicine, Lund, SWE
7ICAN Digital Precision Cancer Medicine Flagship, Helsinki, Finland
8Lund University, Lund, SWE
9Hematology Research Unit Helsinki, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
10Hematology Research Unit Helsinki, Helsinki University Hospital Comprehensive Ca, Helsinki, FIN
11Finnish Red Cross Blood Service (histocompatibility Testing Laboratory), Helsinki, FIN
12Uppsala Uninversity, Uppsala, Sweden
13St. Olav's Hospital - Trondheim Univ. Hosp., Trondheim, NOR
14Department of Hematology, Oncology and Immunology, University Hospital Marburg, Marburg, Germany
15Lund Univeristy, Lund, SWE
16Department of Computer Science, Aalto University, Espoo, Finland

Linda Resar, MD1, Zanshe Thompson, PhD, MS2, Li Z Luo, PhD3*, Donna Marie Williams, PhD4*, Liping Li, MD, PhD5*, Leslie Cope, PhD6*, Iliana Herrera, BS5*, Ophelia Rogers4*, Alison R. Moliterno, MD4 and Jerry L. Spivak, MD1

1Department of Medicine, Division of Hematology, Johns Hopkins University School of Medicine, Baltimore, MD
2Hematology, The Johns Hopkins University School of Medicine, Baltimore, MD
3Department of Medicine, Division of Hematology, The Johns Hopkins University School of Medicine, Baltimore, MD
4Division of Hematology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD
5The Johns Hopkins University School of Medicine, Baltimore, MD
6Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD

Mirielle Nauman, PhD1*, Daniele Vanni, MD1,2*, Nicole Arellano, BA1,3, Thao Trang Nguyen4*, James LaBelle5, Caner Saygin, MD6*, Silvia Catricalà, PhD7*, Ilaria Carola Casetti, MD, PhD2*, Oscar Borsani, MD2, Elisa Rumi, MD2*, Daniela Pietra, PhD8* and Shannon Elf, PhD9,10,11

1Ben May Department for Cancer Research, University of Chicago, Chicago, IL
2Department of Molecular Medicine, University of Pavia, Pavia, Italy
3Committee on Cancer Biology, University of Chicago, Chicago, IL
4Department of Pediatrics, Section of Hematology and Oncology, University of Chicago, Chicago, IL, Chicago, IL
5University of Chicago, Chicago, IL
6Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL
7Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
8U.O.C Ematologia 1, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
9Division of Biological Sciences, The University of Chicago, Chicago, IL
10University of Chicago, The Ben May Department for Cancer Research, Chicago, IL
11University of Chicago, The Committee on Cancer Biology, Chicago, IL

Alissa Oakes, BS1*, Dennis M Bonal, MSc, BSc2, Zoe Creane1*, Hyunju Oh, BS3*, Anna Dorota Chorzalska, PhD4*, Brooke Sadler, PhD5, John L. Reagan, MD6,7, Rabin Niroula8*, Adam J Olszewski, MD1,9,10,11, Gabriel Haller, PhD12*, Stephen Donnelly, BS13* and Patrycja M Dubielecka, PhD14,15*

1Brown University, Providence, RI
2Pathobiology Graduate Program, Brown University, Douglas, MA
3Warren Alpert Medical School, Brown University, Providence, RI
4Signal Transduction Lab, Rhode Island Hospital, Providence, RI
5Pediatrics, Washington University School of Medicine, Saint Louis, MO
6Legorreta Cancer Center of Brown University, Providence, RI
7Warren Alpert Medical School of Brown University, Providence, RI
8Lifespan Cancer Institute, The Warren Alpert Medical School of Brown University, Providence, RI
9Lifespan Cancer Institute, Warren Alpert Medical School of Brown University, Providence, RI
10Lifespan Cancer Institute, Providence, RI
11Legorreta Cancer Center at Brown University, Lifespan Cancer Institute, Providence, RI
12Washington University at St. Louis, St. Louis, MO
13Lifespan Oncology Clinical Research, Rhode Island Hospital, Providence, RI
14Rhode Island Hospital and Warren Alpert Medical School At Brown University, Providence, RI
15Pathobiology Graduate Program, Brown University, Providence, RI

Dennis M Bonal, MSc, BSc1,2,3, Anna Dorota Chorzalska, PhD2,3*, Alissa Oakes, BS2,4*, Makayla Pardo2,5*, Zoe Creane2,4*, Seo-Ho Lee2,6*, Omonike Oyelola3*, John L. Reagan, MD2,3,7, Adam Olszewski, MD3,8,9*, Rabin Niroula, MBBS2,7, Stephen Donnelly, BS10*, Joslyn Mills, PhD11*, Paul Bertone, PhD2,3* and Patrycja M Dubielecka, PhD2,3,5*

1Pathobiology Graduate Program, Brown University, Douglas, MA
2Legorreta Cancer Center of Brown University, Providence, RI
3Warren Alpert Medical School of Brown University, Providence, RI
4Brown University, Providence, RI
5Pathobiology Graduate Program, Brown University, Providence, RI
6Brown University, Amherst, MA
7Legorreta Cancer Center, Lifespan Cancer Institute Providence, Providence, RI
8Legorretta Cancer Center of Brown University, Providence, RI
9Legorreta Cancer Center at Brown University, Lifespan Cancer Institute Providence, Providence, RI
10Lifespan Oncology Clinical Research, Rhode Island Hospital, Providence, RI
11Biology Department, Bridgewater State University, Bridgewater, MA

Malin S. Nilsson1*, Hana Komic, MSc2*, Johan Gustafsson, PhD2*, Zahra Sheybani, MSc2*, Sanchari Paul, MSc2*, Ola Rolfson, MD, PhD3*, Kristoffer Hellstrand, MD, PhD2*, Lovisa Wennström, MD, PhD4*, Anna Martner, PhD2* and Fredrik B. Thorén2*

1Institute of Biomedicine, Gothenburg, Sweden
2TIMM Laboratory at Sahlgrenska Center for Cancer Research, Institute of Biomedicine, University of Gothenburg, Gothenburg, Sweden
3Department of Orthopaedics, Institute of Clinical Sciences, University of Gothenburg, Gothenburg, Sweden
4Department of Hematology, Sahlgrenska University Hospital, Gothenburg, Sweden

Fang Chen1*, Dandan Zhao1, Yi Zhang1,2*, Yongfang Xu1*, Min-Hsuan Chen3*, Khyatiben V. Pathak4,5*, Yong Liang6*, Wei-Le Wang7*, Katrina Estrella1*, Xiwei Wu, PhD, MD3*, Lucy Y. Ghoda, PhD1*, Ya-Huei Kuo, PhD1, Haris Ali, MD1, Jianhua Yu, PhD8, Michael A Caligiuri, MD9, Mark Boldin7*, Piotr Swiderski6*, Marcin Kortylewski, PhD10*, Patrick Pirrotte4,5*, Le Xuan Truong Nguyen, PhD1,4*, Guido Marcucci, MD1 and Bin Zhang1*

1Department of Hematologic Malignancies Translational Science, Gehr Family Center for Leukemia Research, City of Hope National Medical Center and Beckman Research Institute, Duarte, CA
2Department of Hematology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China
3City of Hope National Medical Center, Integrative Genomics Core, Department of Computational and Quantitative Medicine, Beckman Research Institute, Duarte, CA
4Cancer & Cell Biology Division, Translational Genomics Research Institute, Phoenix, AZ
5Integrated Mass Spectrometry Shared Resource, City of Hope Comprehensive Cancer Center, Duarte, CA
6DNA/RNA Peptide Shared Resources, Beckman Research Institute, Duarte, CA
7Department of Systems Biology, Beckman Research Institute of City of Hope, Duarte, CA
8Department of Hematology & Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
9Department of Hematology & Hematopoietic Cell Transplantation, City of Hope National Medical Center, Los Angeles, CA
10Department of Immuno-Oncology, Beckman Research Institute, City of Hope, Duarte, CA

Izabela Aparecida Lopes1*, Camila Araújo Bernardino Garcia1*, Leticia Olops Marini1*, Amanda Fernandes Oliveira Costa1*, Larissa Sarri Binelli1*, Mariana Medeiros1*, Josiane Lillian Schiavinato1*, Priscila Santos Scheucher, PhD2*, Cleide Lúcia Araújo Silva3* and Lorena Lobo Figueiredo-Pontes1

1Division of Hematology, Hemotherapy, and Cellular Therapy, Department of Medical Imaging, Hematology, and Clinical Oncology, Ribeirao Preto Medical School, University of Sao Paulo (FMRP-USP), Ribeirao Preto, SP, Brazil., Ribeirão Preto, Brazil
2Division of Hematology, Hemotherapy, and Cellular Therapy, Department of Medical Imaging, Hematology, and Clinical Oncology, Ribeirao Preto Medical School, University of Sao Paulo (FMRP-USP), Ribeirao Preto, SP, Brazil., Ribeirao Preto, BRA
3Blood Center of Ribeirao Preto, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, SP, Brazil., Ribeirão Preto, Brazil

David Frankhouser1*, Dandan Zhao2*, Russell C. Rockne, PhD3*, Sergio Branciamore, PhD3*, Lisa Uechi3*, Denis O'Meally, PhD3*, Ya-Huei Kuo, PhD4, Bin Zhang2* and Guido Marcucci, MD5

1Department of Computational and Quantitative Medicine, Beckman Research Institute, City of Hope, Beckman Research Institute, Duarte, CA
2Department of Hematologic Malignancies Translational Science, Gehr Family Center for Leukemia Research, City of Hope National Medical Center and Beckman Research Institute, Duarte, CA
3Department of Computational and Quantitative Medicine, Beckman Research Institute, City of Hope National Medical Center, Duarte, CA
4Department of Hematologic Malignancies Translational Science, Gehr Family Center for Leukemia Research, Beckman Research Institute, City of Hope National Medical Center, Duarte, CA
5Department of Hematological Malignancies Translational Science, Gehr Family Center for Leukemia Research, Hematologic Malignancies and Stem Cell Transplantation Institute, Beckman Research Institute, City of Hope National Medical Center, Duarte, CA

Hung Chang, MD1,2*, Hsiao-Wen Kao, MD2*, Ming-Chung Kuo2*, Jin-Hou Wu2*, Ying-Jung Huang2*, Ting-Yu Huang2*, Tung-Huei Lin2* and Lee-Yung Shih, MD1,2

1Chang Gung University, Taoyuan, Taiwan
2Chang Gung Memorial Hospital, Taoyuan, Taiwan

Meenu Kesarwani1*, Mohammad Azhar2*, Sekhu Ansari3*, Zachary Kincaid, BS2* and Mohammad Azam, PhD2,4

1Cincinnati Childrens Hospital Medical Center, Mason, OH
2Cincinnati Children's Hospital Medical Center, Cincinnati, OH
3Cincinnati Childrens Hospital Medical Center, Cincinnati, OH
4Cincinnati Children's Hospital, Cincinnati, OH

Kei Nakajima, MD1* and Keita Kirito, MD2

1Hematology and Oncology, University of Yamanashi, CHUO-SHI, YAMANASHI, Japan
2Department of Hematology and Oncology, University of Yamanashi, Chuo, Japan

Si Tuen Lee-Hoeflich1*, Christopher Brueckner1*, Lawrence Litalien1*, Ke Xu2*, Sharmila Das2*, Laura Corella2*, Sherif Daouti2*, Oriana Esposito3*, Emma Lees1*, Yu Liu1*, Zariana Nikolova3*, Christopher Tehlirian1*, Shodeinde Coker2 and Bin Wu1*

1Bristol Myers Squibb, Cambridge Crossing, MA
2Bristol Myers Squibb, Princeton, NJ
3Bristol Myers Squibb, Neuchatel, Switzerland

Christophe Desterke, PhD1*, Annelise Bennaceur Griscelli, MD, PhD2,3,4* and Ali Turhan, MD, PhD2,5,6

1Faculty of Medicine, University Paris Saclay, Le Kremlin Bicetre, France
2Inserm U1310, Villejuif, France
3Center for iPSC Therapies, Evry Genopole, France
4University Paris Saclay-Division of Hematology, 94805, Villejuif, FRA
5Hopital Bicetre-Paris Sud 11 University, Le Kremlin Bicetre, France
6CITHERA, Center for iPSC Therapies, Evry, France

Benjamin Rolles, MD1, Cilomar Martins De Oliveira Filho, MD2, Julia Keating, MS3*, Marlise R. Luskin, MD, MSCE4, Daniel J. DeAngelo4, Coleman Lindsley, MD, PhD4, Annette S. Kim, MD, PhD5,6, Jessica Hem7*, Chulwoo J. Kim8*, Lachelle D. Weeks, MD, PhD9, Mohammed Wazir10, Joan How, MD9,11, Anna E. Marneth, PhD11,12, Yiwen Liu, MS3*, Martin J. Aryee, PhD3,13*, Harrison K. Tsai, MD, PhD5,14*, Maximilian Stahl, MD15 and Ann Mullally, MD9,11,16

1Division of Hematology, Department of Medicine, Brigham and Women's Hospital/Harvard Medical School, Boston, MA
2Department of Medicine, Mass General Brigham, Salem Hospital, Salem, MA
3Department of Data Science, Dana-Farber Cancer Institute, Boston, MA
4Dana-Farber Cancer Institute, Boston, MA
5Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA
6Department of Pathology, University of Michigan, Ann Arbor, MI
7Division of Hematology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA
8Department of Medicine, Division of Hematology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA
9Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
10Department of Medicine, Division of General Internal Medicine, Brigham and Women's Hospital, Boston, MA
11Division of Hematology, Department of Medicine, Brigham and Women's Hospital, Boston, MA
12Department of Laboratory Medicine, Division Laboratory of Hematology, Radboud University Medical Center, Nijmegen, Netherlands
13Broad Institute of MIT and Harvard, Cambridge, MA
14Department of Pathology, Boston Children’s Hospital, Boston, MA
15Dana Farber Institute, Boston, MA
16Broad Institute, Cambridge, MA

Laetitia Borderon1*, Jihyun Song2*, Soo Jin Kim, MS2*, Christophe Marzac3*, Christine Bellanné-Chantelot4*, Nicolas Papadopoulos5,6*, Stefan N. Constantinescu, MD, PhD7,8, William Vainchenker, MD, PhD1*, Isabelle Plo, MD, PhD9*, Josef T. Prchal, MD2 and Caroline Marty, PhD1*

1INSERM UMR1287, Gustave Roussy, Paris-Saclay University, Villejuif, France
2Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
3Laboratoire d'Immuno-Hématologie, INSERM UMR1287, Gustave Roussy, Paris-Saclay University, Villejuif, France
4INSERM UMR1287, Gustave Roussy, Villejuif, France
5Université catholique de Louvain and de Duve Institute, Brussels, Belgium
6Ludwig Institute for Cancer Research, Brussels, Belgium
7WELBIO (Wallon Excellence in Life Sciences and Biotechnology), Brussels, Belgium
8Oxford University, Nuffield Department of Medicine, Ludwig Institute for Cancer Research, Oxford, United Kingdom
9INSERM, Villejuif, France

Jihyun Song, PhD and Josef T. Prchal, MD

Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT

Rodrigo Gil-Manso1*, Gonzalo Carreño, MD, PhD1*, Juan Carlos Hernandez Boluda, MD, PhD2*, Raul Perez Lopez, MD, PhD3*, Maria Teresa Gómez-Casares, MD, PhD4*, Francisca Ferrer Marin, MD, PhD5, Eduardo Arellano-Rodrigo, MD6*, Anna Angona, PhD7*, Valentín García Gutiérrez, PhD8, Maria Soledad Noya9*, María Alicia Senin, MD, PhD10*, Elena Magro11*, Irene Pastor12*, María Isabel Mata13*, Beatriz Cuevas14*, Elvira Mora, MD, PhD15*, Cristina Martinez, PhD16*, Juan M. Alonso-Dominguez, MD, PhD17*, Manuel Pérez-Encinas18*, Gonzalo Caballero Navarro19*, Miguel A. Cortes Vázquez20*, Carmen del Río1*, Joaquin Martinez Lopez, PhD, MD1*, Rosa Ayala, MD, PhD21* and Alberto Alvarez-Larran, MD22*

1Hospital Universitario 12 de Octubre, Madrid, Spain
2Hospital Clínico Universitario-INCLIVA, Valencia, Spain
3Hospital Universitario Virgen de la Arrixaca, Murcia, Spain
4Hospital Universitario de Gran Canaria Dr. Negrín. Universidad de Las Palmas de Gran Canaria., Las Palmas de Gran Canaria, Spain
5Hospital Universitario Morales Meseguer. Centro Regional de Hemodonación. Universidad de Murcia. IMIB-Arrixaca, Murcia, Spain
6Department of Hemotherapy and Hemostasis, Hospital Clinic, Barcelona, Spain
7Hospital Universitario Doctor Josep Trueta - ICO, Girona, Spain
8Hospital Universitario Ramón y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Universidad de Alcalá, Madrid, Spain
9Hematology Department, University Hospital Juan Canalejo-CHUAC, La Coruña, Spain
10Institut Català d’Oncologia, Hospital Duran i Reynals. Institut d’Investigació Biomèdica de Bellvitge (IDIBELL). Universitat de Barcelona, Barcelona, Spain
11Hematology Department. Hospital Príncipe de Asturias, Alcalá de Henares, Spain., Alcalá de Henares, Spain
12Hematology Department. Hospital Clínico, Valencia, Spain, Valencia, Spain
1312. Hematology Department. Hospital Costa del Sol, Marbella, Spain, Marbella, Spain
14Hospital de Burgos, BURGOS, ESP
15Hematology Research Group, Instituto de Investigación Sanitaria La Fe, Valencia, Spain
16Hospital Galdakao-Usansolo, Galdakao, Spain, Galdakao, Spain
17Instituto De InvestigacióN Sanitaria FundacióN JiméNez D, Madrid, ESP
18Hospital Clínico Universitario, Santiago de Compostela, Spain., Santiago, Spain
1918. Hematology Department. Hospital Miguel Servet, Zaragoza, Spain., Zaragoza, ESP
20Hematology Department. Hospital Marqués de Valdecilla, Santander, Spain, Santander, Spain
21Hematology Department, Hospital 12 de Octubre (i+12), Centro Nacional de Investigaciones Oncológicas (CNIO), Complutense University, Madrid, Spain
22Hematology Department, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain

*signifies non-member of ASH